Touchlight welcomes Dr. Geoff Smith
- Posted on 19 May, 2017
Touchlight is very pleased to welcome Dr. Geoff Smith as the Head of Innovations. Geoff brings extensive experience in genomics technologies and applications, with roles including Vice President leading Technology Development at Illumina and CEO of Cambridge Epigenetix.
Geoff is a world expert in genomics technologies and their applications. He spent more than 10 years working at Solexa/Illumina, where he led the invention of many aspects of the core SBS sequencing chemistry, workflows and platforms, becoming Vice President leading Technology Development globally and clinical product development for cell-free DNA testing in pregnancy (NIPT). After leaving Illumina, Geoff was CEO of Cambridge Epigenetix, a spin-out from Cambridge University, and now works closely with a number of biotech companies in the genomics space.
Share this article:
People also read
Measurement for Recovery
Measurement for RecoveryNew programme to help boost competitiveness and resilience of UK industry, led by the National Physical Laboratory (NPL)NPL is...
SynbiTECH2020 is going virtual!
SynbiTECH 2020 is now entirely virtual to ensure everyone can join us to discuss the latest transformations in synthetic biology and its contribution to the global bioeconomy.
Evonetix raises $30 million USD (£23 million GBP)
Series B investment led by west-coast investor Foresite Capital, with all existing investors participating in the roundFunds will be used to accelerat...